» Articles » PMID: 35481680

Developing Image Analysis Methods for Digital Pathology

Overview
Journal J Pathol
Specialty Pathology
Date 2022 Apr 28
PMID 35481680
Authors
Affiliations
Soon will be listed here.
Abstract

The potential to use quantitative image analysis and artificial intelligence is one of the driving forces behind digital pathology. However, despite novel image analysis methods for pathology being described across many publications, few become widely adopted and many are not applied in more than a single study. The explanation is often straightforward: software implementing the method is simply not available, or is too complex, incomplete, or dataset-dependent for others to use. The result is a disconnect between what seems already possible in digital pathology based upon the literature, and what actually is possible for anyone wishing to apply it using currently available software. This review begins by introducing the main approaches and techniques involved in analysing pathology images. I then examine the practical challenges inherent in taking algorithms beyond proof-of-concept, from both a user and developer perspective. I describe the need for a collaborative and multidisciplinary approach to developing and validating meaningful new algorithms, and argue that openness, implementation, and usability deserve more attention among digital pathology researchers. The review ends with a discussion about how digital pathology could benefit from interacting with and learning from the wider bioimage analysis community, particularly with regard to sharing data, software, and ideas. © 2022 The Author. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Citing Articles

Application and Validation of Semiautomatic Quantification of Immunohistochemically Stained Sections for Low Cellular Tissue Such as Intervertebral Disc Using QuPath.

Nuesch A, Ferri M, Le Maitre C JOR Spine. 2025; 8(1):e70054.

PMID: 40061888 PMC: 11885164. DOI: 10.1002/jsp2.70054.


Deep learning-based image analysis in muscle histopathology using photo-realistic synthetic data.

Mill L, Aust O, Ackermann J, Burger P, Pascual M, Palumbo-Zerr K Commun Med (Lond). 2025; 5(1):64.

PMID: 40050400 PMC: 11885816. DOI: 10.1038/s43856-025-00777-y.


Neuropathological stages of neuronal, astrocytic and oligodendrocytic alpha-synuclein pathology in Parkinson's disease.

Otero-Jimenez M, Wojewska M, Binding L, Jogaudaite S, Gray-Rodriguez S, Young A Acta Neuropathol Commun. 2025; 13(1):25.

PMID: 39934841 PMC: 11816504. DOI: 10.1186/s40478-025-01944-x.


Using digital pathology to standardize and automate histological evaluations of environmental samples.

Tanabe P, Schlenk D, Forsgren K, Pampanin D Environ Toxicol Chem. 2025; 44(2):306-317.

PMID: 39919237 PMC: 11816309. DOI: 10.1093/etojnl/vgae038.


Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer.

Zheng J, Wang T, Wang H, Yan B, Lai J, Qiu K Ann Surg Oncol. 2024; 32(2):771-782.

PMID: 39614006 DOI: 10.1245/s10434-024-16519-8.


References
1.
Rueden C, Ackerman J, Arena E, Eglinger J, Cimini B, Goodman A . Scientific Community Image Forum: A discussion forum for scientific image software. PLoS Biol. 2019; 17(6):e3000340. PMC: 6602289. DOI: 10.1371/journal.pbio.3000340. View

2.
Xie W, Reder N, Koyuncu C, Leo P, Hawley S, Huang H . Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning-Assisted Gland Analysis. Cancer Res. 2021; 82(2):334-345. PMC: 8803395. DOI: 10.1158/0008-5472.CAN-21-2843. View

3.
Fu Y, Jung A, Torne R, Gonzalez S, Vohringer H, Shmatko A . Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis. Nat Cancer. 2022; 1(8):800-810. DOI: 10.1038/s43018-020-0085-8. View

4.
Coulter C, McKay F, Hallowell N, Browning L, Colling R, Macklin P . Understanding the ethical and legal considerations of Digital Pathology. J Pathol Clin Res. 2021; 8(2):101-115. PMC: 8822384. DOI: 10.1002/cjp2.251. View

5.
Harvey J, Clark G, Osborne C, Allred D . Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999; 17(5):1474-81. DOI: 10.1200/JCO.1999.17.5.1474. View